CardioNet taps Thurman as president, CEO

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
The board of directors at CardioNet, a developer of wireless cardiac arrhythmia monitoring devices, has appointed its chairman Randy Thurman as president and CEO, who has served as interim president and CEO since January.

Previously, Thurman served as chairman and CEO of Viasys Healthcare, a medical technology company that was acquired by Cardinal Health, according to the Conshohocken, Pa.-based company.

Prior to that, Thurman was chairman of the board and CEO of Corning Life Sciences, a medical technology company with a focus in contract pharmaceutical research, contract biologic manufacturing and clinical diagnostic testing. Earlier in his career, Thurman was President of Rhone-Poulenc Rorer Pharmaceuticals, a research-based pharmaceutical company.

Justine Varieur Cadet

Related Content

Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.